Non-small cell lung cancer research: advances and persistent challenges

Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality, prompting significant advancements in therapeutic and precision medicine. Recent innovations include antibody-drug conjugates (ADCs) such as TROP-2-targeting agents and HER3-DXd, which show promising efficacy in...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Lin Zhou, Jiakang Jiang
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2026-04-01
Saila:	Frontiers in Oncology
Gaiak:	acquired resistance antibody-drug conjugates biomarker validation geriatric oncology therapeutic accessibility
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1729747/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!